Do anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization?
Immobilization of anti-CD34 antibody on SES enhances endothelialization and may potentially be an effective therapeutic alternative to improve currently available drug-eluting stents.
GSTM1 and GSTP1 are important cytoprotective factors that reduce SHS and DEP exacerbation of allergic responses.